Literature DB >> 19657690

Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population.

Lian Hong Li1, Hai Feng Pan, Wen Xian Li, Xiang Pei Li, Jian Hua Xu, Dong Qing Ye.   

Abstract

Systemic lupus erythematosus (SLE) is a complex autoimmune disease affecting multiple organs/systems with variable activities. We performed a retrospective study to investigate the relationship of clinical characteristics and complications with SLE activity in Chinese Han population. A cohort of 1,490 SLE inpatients was evaluated for disease activity using the systemic lupus erythematosus disease activity index (SLEDAI). Chi-square test or Fisher's exact test was used to compare differences of clinical and laboratory features between active and inactive SLE patients. Logistic regression was chosen to explore the pattern of risk factors for disease activity. We found that neuropsychiatric involvement, nephritis, arthralgia, anti-dsDNA, serositis, hypocomplementemia, oral ulcerations, erythrocyte sedimentation rate, low C3, hematological abnormalities, and systolic pressure (1.010 < odds ratio < 10.568, 1.002 < 95% confidence interval < 31.599, 0.000 < P < 0.026) were major factors associated with disease activity, but not headaches, anti-ribonucleoprotein or anti-Sm, C-reactive protein, and anemia (P > 0.05, respectively). The involvements of urinary system, respiratory system, and central nervous system were significantly more frequent in active SLE than inactive SLE (0.000 < P < 0.014), except for alimentary system (P = 0.399). Our study has comprehensively evaluated the relationship of clinical characteristics and organs/systems involvement of SLE with SLEDAI in Chinese Han population and presented a compendium of factors affecting SLE, which should be useful for better evaluating disease activity and predicting organs/systems damage in SLE for clinical assessments and managements.

Entities:  

Mesh:

Year:  2009        PMID: 19657690     DOI: 10.1007/s10067-009-1240-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  32 in total

1.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

2.  Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.

Authors:  Luis M Vilá; Graciela S Alarcón; Gerald McGwin; Holly M Bastian; Barri J Fessler; John D Reveille
Journal:  Arthritis Rheum       Date:  2006-10-15

Review 3.  Autoantibody determination in the diagnosis of systemic lupus erythematosus.

Authors:  B T Kurien; R H Scofield
Journal:  Scand J Immunol       Date:  2006-09       Impact factor: 3.487

4.  Development of anti-Sm and anti-DNA antibodies followed by clinical manifestation of systemic lupus erythematosus in an elderly woman with long-standing Sjögren's syndrome.

Authors:  M Satoh; H Yamagata; F Watanabe; S Nakayama; T Ogasawara; T Tojo; M Akizuki
Journal:  Lupus       Date:  1995-02       Impact factor: 2.911

5.  Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus.

Authors:  R Prasad; D Ibañez; D Gladman; M Urowitz
Journal:  Lupus       Date:  2006       Impact factor: 2.911

Review 6.  Lupus update: perspective and clinical pearls.

Authors:  Susan Manzi
Journal:  Cleve Clin J Med       Date:  2009-02       Impact factor: 2.321

7.  Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study.

Authors:  M Petri; M Genovese; E Engle; M Hochberg
Journal:  Arthritis Rheum       Date:  1991-08

Review 8.  Serological markers of disease activity in systemic lupus erythematosus.

Authors:  P E Spronk; P C Limburg; C G Kallenberg
Journal:  Lupus       Date:  1995-04       Impact factor: 2.911

9.  Serum soluble nucleosome and the broad family of antinucleosome antibodies are associated with organ and tissue damage in systemic lupus erythematosus in a Chinese population.

Authors:  O Wu; H H Liu; W X Li; N Zhang; Q Wang; X P Li; M X Dong; X J Zhang; D Q Ye
Journal:  Clin Exp Dermatol       Date:  2008-03       Impact factor: 3.470

10.  Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.

Authors:  M Ramos-Casals; M T Campoamor; A Chamorro; G Salvador; S Segura; J C Botero; J Yagüe; R Cervera; M Ingelmo; J Font
Journal:  Lupus       Date:  2004       Impact factor: 2.911

View more
  7 in total

1.  Impact of follow-up visits on disease outcome in Chinese systemic lupus erythematosus.

Authors:  Huanhuan Ma; Jing Dong; Liqin Wang; Lei Zhao; Lin Pan
Journal:  Clin Rheumatol       Date:  2017-08-03       Impact factor: 2.980

2.  Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus.

Authors:  Corinna E Weckerle; Beverly S Franek; Jennifer A Kelly; Marissa Kumabe; Rachel A Mikolaitis; Stephanie L Green; Tammy O Utset; Meenakshi Jolly; Judith A James; John B Harley; Timothy B Niewold
Journal:  Arthritis Rheum       Date:  2011-04

3.  The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study.

Authors:  Yan Liang; Rui-Xue Leng; Hai-Feng Pan; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2016-12-20       Impact factor: 2.631

4.  Relationship between hyperuricemia and serositis in patients with lupus nephritis.

Authors:  Ping Nie; Liangqian Hu; Bing Li; Yan Lou; Manyu Luo; Yali Wang; Xuehong Lu; Ping Luo
Journal:  Int Urol Nephrol       Date:  2021-05-10       Impact factor: 2.370

5.  Correlation of plasma and urine Wnt5A with the disease activity and cutaneous lesion severity in patients with systemic lupus erythematosus.

Authors:  Shuhong Chi; Jing Xue; Xiaodong Chen; Xiaoming Liu; Yanhong Ji
Journal:  Immunol Res       Date:  2021-12-03       Impact factor: 2.829

6.  Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study.

Authors:  L Langensee; J Mårtensson; A Jönsen; K Zervides; A Bengtsson; J Nystedt; B Cannerfelt; P Nilsson; P Mannfolk; J Lätt; T Rumetshofer; P C Sundgren
Journal:  BMC Rheumatol       Date:  2022-04-20

7.  Risk factors for the flare of systemic lupus erythematosus and its influence on prognosis: a single-center retrospective analysis.

Authors:  Xiaohong Zeng; Ling Zheng; Hongbing Rui; Rihui Kang; Junmin Chen; Huaning Chen; Jizan Liu
Journal:  Adv Rheumatol       Date:  2021-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.